CDK4/6 Inhibitors Induce Antitumor Immunity
- PMID: 28864481
- DOI: 10.1158/2159-8290.CD-NB2017-122
CDK4/6 Inhibitors Induce Antitumor Immunity
Abstract
CDK4/6 inhibitors not only induce cell-cycle arrest but also promote antitumor immunity by stimulating the production of type III interferons, which enhance tumor antigen presentation, and suppress regulatory T cells. The immune effects of these drugs provide a rationale for combining CDK4/6 inhibitors with checkpoint blockade agents.
©2017 American Association for Cancer Research.
Comment on
-
CDK4/6 inhibition triggers anti-tumour immunity.Nature. 2017 Aug 24;548(7668):471-475. doi: 10.1038/nature23465. Epub 2017 Aug 16. Nature. 2017. PMID: 28813415 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
